Literature DB >> 26073736

A Epidemiological Investigation of a Nosocomial Outbreak of Multidrug-Resistant Acinetobacter baumannii in a Critical Care Center in Japan, 2011-2012.

Hiroto Ushizawa1, Yuichiro Yahata, Takeo Endo, Tomoko Iwashima, Michiyo Misawa, Makoto Sonobe, Takuya Yamagishi, Hajime Kamiya, Kazutoshi Nakashima, Tamano Matsui, Mari Matsui, Satowa Suzuki, Keigo Shibayama, Mikio Doi, Fujiko Irie, Shinichi Yamato, Yasuhiro Otomo, Kazunori Oishi.   

Abstract

In 2011, a multidrug-resistant Acinetobacter baumannii (MDRAB) outbreak occurred at a Japanese critical care center (CCC) in a tertiary care hospital. Multidrug-resistance in Japan is defined as resistance to the antimicrobials amikacin, carbapenem, and fluoroquinolone. We conducted a retrospective epidemiological investigation of this outbreak to identify the risk factors for MDRAB respiratory tract acquisition in this hospital. Cases were defined as hospitalized patients with MDRAB-positive cultures at least 3 days post admission to the CCC between June 1, 2011 and April 20, 2012. Fifteen MDRAB cases were identified, including 3 with infection and 12 with colonization. This case-control study demonstrated that hypoalbuminemia along with carbapenem administration were associated with MDRAB respiratory tract acquisition. Pulsed-field gel electrophoresis analysis and multilocus sequence typing using MDRAB isolates suggested a clonal dissemination of MDRAB strains with sequence type 74 occurred primarily among patients admitted to the CCC. From April 16, 2012, a decreased isolation rate of MDRAB in the hospital occurred after the implementation of the following infection control measures: closing the emergency room, discontinuing admission to the CCC, isolating patients with MDRAB colonization or infection to single room status, and conducting environmental cleaning. No MDRAB cases were detected between March 23 and April 20, 2012.

Entities:  

Mesh:

Year:  2015        PMID: 26073736     DOI: 10.7883/yoken.JJID.2015.049

Source DB:  PubMed          Journal:  Jpn J Infect Dis        ISSN: 1344-6304            Impact factor:   1.362


  5 in total

1.  Distribution and Molecular Characterization of Acinetobacter baumannii International Clone II Lineage in Japan.

Authors:  Mari Matsui; Masato Suzuki; Masahiro Suzuki; Jun Yatsuyanagi; Masanori Watahiki; Yoichi Hiraki; Fumio Kawano; Atsuko Tsutsui; Keigo Shibayama; Satowa Suzuki
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

2.  Analysis of Immune Responses in Acinetobacter baumannii-Infected Klotho Knockout Mice: A Mouse Model of Acinetobacter baumannii Infection in Aged Hosts.

Authors:  Yoshinori Sato; Shigeru Tansho-Nagakawa; Tsuneyuki Ubagai; Yasuo Ono
Journal:  Front Immunol       Date:  2020-11-23       Impact factor: 7.561

3.  Histopathological Analysis of Acinetobacter baumannii Lung Infection in a Mouse Model.

Authors:  Shigeru Tansho-Nagakawa; Yoshinori Sato; Tsuneyuki Ubagai; Takane Kikuchi-Ueda; G O Kamoshida; Satoshi Nishida; Yasuo Ono
Journal:  Pol J Microbiol       Date:  2021-12-23

4.  Sub-minimum inhibitory concentrations of colistin and polymyxin B promote Acinetobacter baumannii biofilm formation.

Authors:  Yoshinori Sato; Yuka Unno; Tsuneyuki Ubagai; Yasuo Ono
Journal:  PLoS One       Date:  2018-03-19       Impact factor: 3.240

5.  Molecular Characterization and Antibiotic Susceptibility Pattern of Acinetobacter Baumannii Isolated in Intensive Care Unit Patients in Al-Hassa, Kingdom of Saudi Arabia.

Authors:  Mohammed Sami Alhaddad; Afnan Khalifah AlBarjas; Lolowah Ebraheem Alhammar; Abdullatif Sami Al Rashed; Lorina Ineta Badger-Emeka
Journal:  Int J Appl Basic Med Res       Date:  2018 Jan-Mar
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.